O26.4 Herpes gestationis

Name of the Condition

• Herpes gestationis
• ICD Code: O26.4

Summary

Herpes gestationis is a rare, pregnancy-associated autoimmune blistering disorder that typically presents in the second or third trimester. It is characterized by pruritic (itchy) papules and vesicles, primarily affecting the abdomen, trunk, and extremities. The condition is not related to herpes simplex virus but is linked to immune system changes during pregnancy. It usually resolves postpartum but may recur in subsequent pregnancies or with hormonal changes.

Causes

Herpes gestationis is an autoimmune disorder where the immune system produces antibodies targeting components of the skin, particularly the basement membrane zone. The exact trigger is unclear, but it is associated with pregnancy-related hormonal shifts and may involve genetic predisposition. The condition is not infectious and does not result from viral infection.

Risk Factors

Risk factors include a personal or family history of autoimmune diseases, such as thyroid disorders or celiac disease. Women with a history of herpes gestationis in prior pregnancies are at higher risk of recurrence. The condition is more common in first pregnancies and may be associated with certain HLA (human leukocyte antigen) types.

Symptoms

Symptoms include intense itching (pruritus) followed by the development of red, raised papules or blisters (vesicles) on the abdomen, trunk, or extremities. Lesions may spread to other areas and can become widespread in severe cases. Mucous membranes are rarely affected. Symptoms often worsen in the third trimester and may flare postpartum.

Diagnosis

Diagnosis is based on clinical presentation and confirmed by skin biopsy, which shows subepidermal blistering and eosinophilic infiltration. Direct immunofluorescence testing of perilesional skin typically reveals linear deposition of complement C3 along the basement membrane. Laboratory tests may show elevated eosinophils or IgG antibodies.

Treatment Options

Treatment focuses on symptom relief and preventing complications. Topical or systemic corticosteroids (e.g., prednisone) are commonly used to reduce inflammation and itching. Antihistamines may help manage pruritus. Severe cases may require higher-dose steroids or other immunosuppressants. Close monitoring of maternal and fetal health is essential.

Prognosis and Follow-Up

The prognosis is generally good, with most cases resolving within weeks to months postpartum. However, symptoms may persist or recur in subsequent pregnancies. Fetal outcomes are usually favorable, though rare cases of transient neonatal blistering have been reported. Regular follow-up with a dermatologist or maternal-fetal medicine specialist is recommended to manage symptoms and monitor for recurrence.

Complications

Complications include secondary bacterial infection from scratching, which can lead to scarring. Severe cases may cause significant discomfort and impact quality of life. Rarely, the condition may be associated with preterm labor or low birth weight, though this is not consistently observed. Long-term scarring or post-inflammatory hyperpigmentation may occur.

Lifestyle & Prevention

Avoiding triggers like excessive heat, friction, or harsh soaps can help reduce itching. Keeping the skin moisturized and using cool compresses may provide relief. Stress management and adequate rest are important, as stress can exacerbate symptoms. There is no known prevention, but early recognition and treatment can minimize complications.

When to Seek Professional Help

Seek medical attention if you experience new or worsening skin lesions, severe itching, or signs of infection (e.g., pus, increased pain, or fever). Prompt evaluation is necessary to confirm the diagnosis and initiate treatment. Contact your healthcare provider immediately if symptoms affect daily functioning or if you notice changes in fetal movement.

Tips for Medical Coders

Document the clinical findings, including the presence of pruritic papules or vesicles, affected body areas, and timing relative to pregnancy. Note any biopsy results or immunofluorescence findings to support the diagnosis. Ensure the code O26.4 is used for herpes gestationis and not confused with other blistering disorders. Include details about treatment and follow-up to reflect the complexity of care.